Globus Medical price target raised to $78 from $77 at BTIG — Oct 15th, 2024

https://www.tipranks.com/news/the-fly/globus-medical-price-target-raised-to-78-from-77-at-btig BTIG analyst Ryan Zimmerman raised the firm’s price target on Globus Medical to $78 from $77 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 results in Me...

Globus Medical Schedules Third Quarter Earnings Release and Conference Call — Oct 15th, 2024

Globus Medical AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of...

Globus Medical price target raised to $78 from $77 at BTIG — Oct 15th, 2024

https://www.tipranks.com/news/the-fly/globus-medical-price-target-raised-to-78-from-77-at-btig BTIG analyst Ryan Zimmerman raised the firm’s price target on Globus Medical to $78 from $77 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 results in Me...

Globus Medical Schedules Third Quarter Earnings Release and Conference Call — Oct 15th, 2024

Globus Medical AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of...

GMED or SONVY: Which Is the Better Value Stock Right Now? — Oct 9th, 2024

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and SONOVA HOLDING (SONVY). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. We have found that ...

Globus Medical price target raised to $78 from $77 at BTIG — Oct 15th, 2024

https://www.tipranks.com/news/the-fly/globus-medical-price-target-raised-to-78-from-77-at-btig BTIG analyst Ryan Zimmerman raised the firm’s price target on Globus Medical to $78 from $77 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 results in Me...

Inari Medical Stock Gets RS Rating Upgrade — Dec 11th, 2024

Inari Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Continue reading View comments...

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting — Oct 18th, 2024

Globus Medical AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26. Join Globus at boot...

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting — Oct 18th, 2024

Globus Medical AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26. Join Globus at boot...

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting — Oct 18th, 2024

Globus Medical AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26. Join Globus at boot...

Globus Medical price target raised to $78 from $77 at BTIG — Oct 15th, 2024

https://www.tipranks.com/news/the-fly/globus-medical-price-target-raised-to-78-from-77-at-btig BTIG analyst Ryan Zimmerman raised the firm’s price target on Globus Medical to $78 from $77 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 results in Me...

Globus Medical Expands Orthopedic Trauma Portfolio With New Launches — Oct 10th, 2024

Globus Medical, Inc. GMED recently reported expansion of its rapidly growing orthopedic trauma product portfolio. The latest launched next-generation systems include ANTHEM II Distal Radius Volar Plates, AUTOBAHN Trochanteric Nail PRO Instruments and CAPTIVATE SOLA Headless Screws. To date...

GMED or SONVY: Which Is the Better Value Stock Right Now? — Oct 9th, 2024

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and SONOVA HOLDING (SONVY). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. We have found that ...

Inari Medical Stock Gets RS Rating Upgrade — Dec 11th, 2024

Inari Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Continue reading View comments...

Globus Medical Schedules Third Quarter Earnings Release and Conference Call — Oct 15th, 2024

Globus Medical AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Globus Medical Expands Orthopedic Trauma Portfolio With New Launches — Oct 10th, 2024

Globus Medical, Inc. GMED recently reported expansion of its rapidly growing orthopedic trauma product portfolio. The latest launched next-generation systems include ANTHEM II Distal Radius Volar Plates, AUTOBAHN Trochanteric Nail PRO Instruments and CAPTIVATE SOLA Headless Screws. To date...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Globus Medical Expands Orthopedic Trauma Portfolio With New Launches — Oct 10th, 2024

Globus Medical, Inc. GMED recently reported expansion of its rapidly growing orthopedic trauma product portfolio. The latest launched next-generation systems include ANTHEM II Distal Radius Volar Plates, AUTOBAHN Trochanteric Nail PRO Instruments and CAPTIVATE SOLA Headless Screws. To date...

Globus Medical Schedules Third Quarter Earnings Release and Conference Call — Oct 15th, 2024

Globus Medical AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Globus Medical price target raised to $78 from $77 at BTIG — Oct 15th, 2024

https://www.tipranks.com/news/the-fly/globus-medical-price-target-raised-to-78-from-77-at-btig BTIG analyst Ryan Zimmerman raised the firm’s price target on Globus Medical to $78 from $77 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 results in Me...

Globus Medical Expands Orthopedic Trauma Portfolio With New Launches — Oct 10th, 2024

Globus Medical, Inc. GMED recently reported expansion of its rapidly growing orthopedic trauma product portfolio. The latest launched next-generation systems include ANTHEM II Distal Radius Volar Plates, AUTOBAHN Trochanteric Nail PRO Instruments and CAPTIVATE SOLA Headless Screws. To date...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Globus Medical price target raised to $78 from $77 at BTIG — Oct 15th, 2024

https://www.tipranks.com/news/the-fly/globus-medical-price-target-raised-to-78-from-77-at-btig BTIG analyst Ryan Zimmerman raised the firm’s price target on Globus Medical to $78 from $77 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 results in Me...

Globus Medical Expands Orthopedic Trauma Portfolio With New Launches — Oct 10th, 2024

Globus Medical, Inc. GMED recently reported expansion of its rapidly growing orthopedic trauma product portfolio. The latest launched next-generation systems include ANTHEM II Distal Radius Volar Plates, AUTOBAHN Trochanteric Nail PRO Instruments and CAPTIVATE SOLA Headless Screws. To date...

Globus Medical Expands Orthopedic Trauma Portfolio With New Launches — Oct 10th, 2024

Globus Medical, Inc. GMED recently reported expansion of its rapidly growing orthopedic trauma product portfolio. The latest launched next-generation systems include ANTHEM II Distal Radius Volar Plates, AUTOBAHN Trochanteric Nail PRO Instruments and CAPTIVATE SOLA Headless Screws. To date...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Globus Medical Schedules Third Quarter Earnings Release and Conference Call — Oct 15th, 2024

Globus Medical AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of...

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting — Oct 18th, 2024

Globus Medical AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26. Join Globus at boot...

Globus Medical Expands Orthopedic Trauma Portfolio With New Launches — Oct 10th, 2024

Globus Medical, Inc. GMED recently reported expansion of its rapidly growing orthopedic trauma product portfolio. The latest launched next-generation systems include ANTHEM II Distal Radius Volar Plates, AUTOBAHN Trochanteric Nail PRO Instruments and CAPTIVATE SOLA Headless Screws. To date...

GMED or SONVY: Which Is the Better Value Stock Right Now? — Oct 9th, 2024

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and SONOVA HOLDING (SONVY). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. We have found that ...

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting — Oct 18th, 2024

Globus Medical AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26. Join Globus at boot...

Globus Medical price target raised to $78 from $77 at BTIG — Oct 15th, 2024

https://www.tipranks.com/news/the-fly/globus-medical-price-target-raised-to-78-from-77-at-btig BTIG analyst Ryan Zimmerman raised the firm’s price target on Globus Medical to $78 from $77 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 results in Me...

Globus Medical Schedules Third Quarter Earnings Release and Conference Call — Oct 15th, 2024

Globus Medical AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of...

Globus Medical Schedules Third Quarter Earnings Release and Conference Call — Oct 15th, 2024

Globus Medical AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

GMED or SONVY: Which Is the Better Value Stock Right Now? — Oct 9th, 2024

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and SONOVA HOLDING (SONVY). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. We have found that ...

Globus Medical Schedules Third Quarter Earnings Release and Conference Call — Oct 15th, 2024

Globus Medical AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting — Oct 18th, 2024

Globus Medical AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26. Join Globus at boot...

Globus Medical Expands Orthopedic Trauma Portfolio With New Launches — Oct 10th, 2024

Globus Medical, Inc. GMED recently reported expansion of its rapidly growing orthopedic trauma product portfolio. The latest launched next-generation systems include ANTHEM II Distal Radius Volar Plates, AUTOBAHN Trochanteric Nail PRO Instruments and CAPTIVATE SOLA Headless Screws. To date...

Globus Medical price target raised to $78 from $77 at BTIG — Oct 15th, 2024

https://www.tipranks.com/news/the-fly/globus-medical-price-target-raised-to-78-from-77-at-btig BTIG analyst Ryan Zimmerman raised the firm’s price target on Globus Medical to $78 from $77 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 results in Me...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Novocure Stock Earns 96 RS Rating — Dec 3rd, 2024

On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments...

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting — Oct 18th, 2024

Globus Medical AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26. Join Globus at boot...

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting — Oct 18th, 2024

Globus Medical AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26. Join Globus at boot...

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting — Oct 18th, 2024

Globus Medical AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26. Join Globus at boot...

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting — Oct 18th, 2024

Globus Medical AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26. Join Globus at boot...